The intravascular lithotripsy market has undergone high growth trailblazed by J&J subsidiary Shockwave Medical.
JointMedica, a global leader in orthopedic innovation, announces the commencement of an Investigational Device Exemption (IDE) study for its Polymotion® Hip Resurfacing (PHR®) device. The IDE study ...
Glucotrack (Nasdaq:GCTK) announced that it expects FDA investigational device exemption for its long-term CBGM later this year.
The company is first rolling out the use of the Volt system among European Union doctors who have already gained experience ...
Abbott received FDA investigational device exemption (IDE) approval for its coronary intravascular lithotripsy (IVL) system.
Medical Device Network on MSN6d
Abbott eyes intravascular lithotripsy market with clinical trial approvalThe US Food and Drug Administration (FDA) has granted Abbott an investigational device exemption to evaluate the company’s ...
Abbott begins new Intravascular Lithotripsy trial to improve outcomes in patients with coronary artery disease: Abbott Park, Illinois Wednesday, March 26, 2025, 15:00 Hrs [IST] Ab ...
Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback